20/20 Global (TWGL) Stock Price, News & Analysis

TWGL

Published by Stock Titan Data refreshed March 22, 2021

What Changed

Latest news March 22, 2021
Psychedelic Joint Venture Between Mycotopia Therapies and Natural MedTech Brings Research and Drug Development to Test Active Ingredient In Psychedelics

Company Description

This page collects what Stock Titan holds for TWGL, including price data and latest news.

Stock Performance

—

-

-

-

Performance 1 year

-

-

Shares outstanding

Latest News

March 22, 2021

—

Psychedelic Joint Venture Between Mycotopia Therapies and Natural MedTech Brings Research and Drug Development to Test Active Ingredient In Psychedelics

February 8, 2021

—

Mycotopia Therapies (20/20 Global) to Launch PsyBioMed, a Biosynthetic Compound, a Biotech Company for the Global Production of Psychedelics

February 8, 2021

—

20/20 Global Announces It Has Applied for a Name and Stock Symbol Change with FINRA

20/20 Global has 3 recent news articles. View all TWGL news →

SEC Filings

No SEC filings available for TWGL.